Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

CSE/VTAL stock hub

CSE/VTAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/VTALis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/VTAL

In the news

Latest news · CSE/VTAL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/VTAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

134

Groups with data

Currency

CAD

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 1.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Diagnostics & Research
Last refreshed	2026-05-10
Market cap	CAD 1.2M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	8731
Symbol	cse/VTAL
Website	https://www.justerahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-339.86%
EV Earnings	-0.32x
EV/Sales	0.95x
P/B ratio	-0.33x
P/S ratio	0.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-172.93%
EBITDA Margin	-165.52%
Gross margin	62.11%
Gross Profit	CAD 882,278
Gross Profit Growth	3%
Gross Profit Growth Q	-97.03%
Gross Profit Growth3 Y	-29.22%
Net Income	CAD -4.2M
Pretax Margin	-296.58%
Profit Margin	-296.58%
ROA	-94.73
Roa5y	-28,316.5
ROCE	68.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.02%
Cagr3y	-44.96%
Revenue Growth	-25.79x
Revenue Growth Q	-97.85x
Revenue Growth3 Y	-58.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.88
Assets	CAD 1.6M
Cash	CAD 53,675
Current Assets	CAD 1.4M
Current Liabilities	CAD 5.2M
Debt	CAD 165,157
Equity	CAD -3.7M
Liabilities	CAD 5.3M
Long Term Assets	CAD 148,961
Long Term Liabilities	CAD 130,027
Net Cash	CAD -111,482
Net Cash By Market Cap	CAD -8.99
Tangible Book Value	CAD -3.9M
Tangible Book Value Per Share	CAD -0.02
WACC	9.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.28
Inventory Turnover	7.23
Net Working Capital	CAD -3.7M
Quick ratio	0.25
Working Capital	CAD -3.7M
Working Capital Turnover	CAD -0.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50%
200-day SMA	0.01
3Y total return	-83.33%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
All Time High	3.45
All Time High Change	-99.86%
All Time High Date	2021-03-08
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2024-03-12
ATR	0
Beta	1.27
Beta1y	0
Beta2y	-1.26
High	0.01
High52	0.02
High52 Date	2025-01-20
High52ch	-75%
Low	0.01
Low52	0.01
Low52 Date	2025-08-06
Low52ch	0%
Ma50ch	-24.24%
Price vs 200-day SMA	-41.86%
RSI	42.63
RSI Monthly	9.95
RSI Weekly	44.67
Sharpe ratio	1.82x
Sortino ratio	3.79
Total Return	-39.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.5M
Operating margin	-172.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-55,002
Shares Insiders	16.57%
Shares Out	247,916,983
Shares Qo Q	44.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	853,688.4x
Bv Per Share	-0.02
Ch1y	-50
Ch3y	-83.33
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	105,222
Dollar Volume	500
Earnings Date	2026-05-01
EBIT	CAD -2.5M
EBITDA	CAD -2.4M
EPS	CAD -0.02
F Score	4
Financing CF	-55,002
Fiscal Year End	December
Founded	2,020
Investing CF	-400,685
Is Primary Listing	1
Last Earnings Date	2025-11-24
Last Report Date	2024-12-31
Last Split Date	2022-02-24
Last Split Type	Reverse
Ma150	0.01
Ma150ch	-28.57%
Ma20	0.01
Ma20ch	-13.79%
Net CF	-41,018
Open	0.01
P OCF Ratio	2.99
Ppne	3,012
Price Date	2025-08-06
Relative Volume	0.12x
Revenue	1,420,483x
Volume	100,000
Z Score	-28.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/VTAL pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/VTAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/VTAL?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+16.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

CSE/VTAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.6

Neutral momentum band

Price vs 200-day MA

-41.9%

50/200-day relationship not available

Beta (5Y)

1.27

More volatile than the market

Sharpe ratio

1.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/VTAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/VTAL stock rating?

cse/VTAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/VTAL analysis?

The full report lives at /stocks/cse/VTAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/VTAL?

The latest report frames cse/VTAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/VTAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.